This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Targeting the Endocannabinoid System for Treatment of Human Diseases

Targeting the Endocannabinoid System for Treatment of Human Diseases

Friday, June 19, 2020, 8:30 AM - 6:00 PM

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

The New York Academy of Sciences

 

The endocannabinoid system (ECS) maintains homeostasis in the body by regulating physiologic processes including neurotransmission, mood, energy balance, immune responses, and wound healing. Functions of the ECS are mediated by two cannabinoid receptors, Type 1 and 2 (CB1 and CB2). This meeting will focus on the understanding of the physiology and pharmacology of the peripheral endocannabinoid system. The goal is to illuminate the roles of CB1 and CB2 receptors with regard to possible discovery and development of entirely new classes of drugs for the treatment of inflammatory, immune, and fibrotic disorders.

Call for Abstracts

Abstract submissions are invited for a poster session. For complete submission instructions, please visit our online portal. The deadline for abstract submission is Friday, April 10, 2020.

Registration

Member
By 05/09/2020
$90
After 05/09/2020
$130
Nonmember Academia, Faculty, etc.
By 05/09/2020
$180
After 05/09/2020
$260
Nonmember Corporate, Other
By 05/09/2020
$250
After 05/09/2020
$350
Nonmember Not for Profit
By 05/09/2020
$180
After 05/09/2020
$260
Nonmember Student, Undergrad, Grad, Fellow
By 05/09/2020
$100
After 05/09/2020
$145
Member Student, Post-Doc, Fellow
By 05/09/2020
$50
After 05/09/2020
$70
Earlybird Registration:
80
days
left
Deadline:
51
days
left

Scientific Organizing Committee

Sonya Dougal, PhD

The New York Academy of Sciences

Allyn Howlett, PhD

Wake Forest School of Medicine

George Kunos, MD, PhD

National Institute on Alcohol Abuse and Alcoholism

Barbara White, MD

Corbus Pharmaceuticals

George Zavoico, PhD

B. Riley FBR

Friday

June 19, 2020

8:30 AM

Registration / Check-in / Breakfast

9:00 AM

Opening Remarks

9:15 AM

Biology and Pharmacology of Endocannabinoid System

Speaker

Allyn Howlett
Wake Forest School of Medicine

Session 1: CB1

Session Chairperson
George Kunos, MD, PhD, National Institute on Alcohol Abuse and Alcoholism
10:00 AM

TBD

Speaker

George Kunos, MD, PhD
National Institute on Alcohol Abuse and Alcoholism
10:30 AM

TBD

Speaker

Kathryn Nichol, PhD
Greenwich Biosciences
11:00 AM

Coffee Break

11:20 AM

TBD

Speaker

Kenneth Mackie, MD
Indiana University
11:50 AM

TBD

Speaker

Aron H. Lichtman, Ph.D.
Virginia Commonwealth University
12:20 PM

Panel Discussion

Speakers

Moderator: George Kunos, MD, PhD
National Institute on Alcohol Abuse and Alcoholism
Kathryn Nichol, PhD
Greenwich Biosciences
Kenneth Mackie, MD
Indiana University
Aron H. Lichtman, PhD
Virginia Commonwealth University
12:50 PM

Lunch Break & Poster Session

Session 2: CB2

Session Chairperson
Cecilia J. Hillard, PhD, Medical College of Wisconsin
2:20 PM

Novel Mechanism for the Regulation of Endocannabinoid Signaling

Speaker

Cecilia J. Hillard, PhD
Medical College of Wisconsin
2:50 PM

Harnessing Endocannabinoids for Pro-resolution Purposes

Speaker

Derek Gilroy, PhD
University College London
3:20 PM

TBD

Speaker

Andrea Hohmann, PhD
Indiana University Bloomington
3:50 PM

TBD

Speaker

Barbara White, MD
Corbus Pharmaceuticals
4:20 PM

Coffee Break

4:40 PM

Panel Discussion

Speakers

Moderator: Allyn Howlett, PhD
Wake Forest School of Medicine
Cecilia J. Hillard, PhD
Medical College of Wisconsin
Derek Gilroy, PhD
University College London
Andrea Hohmann, PhD
Indiana University Bloomington
Barbara White, MD
Corbus Pharmaceuticals
5:10 PM

Closing Remarks

5:15 PM

Networking Reception

6:00 PM

Adjourn